Free Trial
Notice: This company has been marked as potentially delisted and may not be actively trading.

VBI Vaccines (VBIV) Insider Trading & Ownership

VBI Vaccines logo

VBI Vaccines (NASDAQ:VBIV) Insider Buying and Selling Activity

Current
Insider Ownership
Percentage
10.35%
Number Of
Insiders Buying
(Last 3 Years)
2
Amount Of
Insider Buying
(Last 3 Years)
$1.03 M
Number Of
Insiders Selling
(Last 3 Years)
1
Amount Of
Insider Selling
(Last 3 Years)
$10.20 M
Get VBIV Insider Trade Alerts

Want to know when executives and insiders are buying or selling VBI Vaccines stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily.

VBIV Insider Buying and Selling by Quarter

VBI Vaccines Insider and Congressional Trades History

Transaction DateNameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails
7/10/2023Steven GillisDirectorBuy609,090$1.65$1,004,998.50  
4/6/2023Perceptive Advisors LlcMajor ShareholderSell212,578$2.20$467,671.60  
4/4/2023Perceptive Advisors LlcMajor ShareholderSell240,531$3.20$769,699.20  
12/3/2021Nell BeattieInsiderBuy410$49.00$20,090.00  
12/1/2021Perceptive Advisors LlcMajor ShareholderSell135,373$66.20$8,961,692.60  
(Data available from 1/1/2013 forward)

VBIV Insider Trading Activity - Frequently Asked Questions

The list of insiders at VBI Vaccines includes Nell Beattie, Perceptive Advisors Llc, and Steven Gillis. Learn more on insiders at VBIV.

10.35% of VBI Vaccines stock is owned by insiders. Learn more on VBIV's insider holdings.

The following insider purchased VBIV shares in the last 24 months: Steven Gillis ($1,004,998.50).

Insiders have purchased a total of 609,090 VBIV shares in the last 24 months for a total of $1,004,998.50 bought.

The following insider sold VBIV shares in the last 24 months: Perceptive Advisors Llc ($1,237,370.80).

Insiders have sold a total of 453,109 VBI Vaccines shares in the last 24 months for a total of $1,237,370.80 sold.



This page (NASDAQ:VBIV) was last updated on 11/21/2024 by MarketBeat.com Staff
From Our Partners